NHI Dropped From Russell 3000 Growth Index Amid Index Shuffle
National Health Investors loses its Russell 3000 Growth spot while preparing to join the S&P SmallCap 600 Index.
National Health Investors (NYSE: NHI) was removed from the Russell 3000 Growth Benchmark, the healthcare REIT confirmed, marking a notable shift in its index standing that could affect institutional investor exposure to the stock.
The removal comes as NHI simultaneously prepares to join the S&P SmallCap 600 Index, a move that signals a reclassification in how major index providers are categorizing the company. Analyst price target adjustments have also followed in recent weeks, adding to a busy stretch of market-structure news for the firm.
Read more Record Debt Issuance of $570B Projected for 2026 Strains Markets →
On the financial side, NHI posted stronger-than-expected Q1 2026 results, reporting increased normalized funds from operations and revenue growth compared to the prior year period. Despite the earnings beat, management lowered its full-year guidance, signaling caution about the pace of growth through the remainder of 2026.
The company also announced a dividend alongside its quarterly results, continuing its payout streak. For income-focused investors, the dual storyline of an index demotion on one hand and a maintained dividend on the other presents a mixed but closely watched picture for this healthcare real estate name.
Continue reading at www.marketscreener.com
